login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Immunomedics Inc (IMMU) Stock News
USA
- NASDAQ:IMMU -
87.86
+0.04 (+0.05%)
Last: 10/22/2020, 8:00:04 PM
87.9
+0.04 (+0.05%)
After Hours:
10/22/2020, 8:00:04 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IMMU Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Bloomberg
- Mentions:
GILD
Gilead Wants Ex-Executive to Repay Millions for Insider Probe
5 years ago - By: Bloomberg
- Mentions:
GILD
SAGE
AMGN
CYTK
...
Gilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for Growth
5 years ago - By: Bloomberg
- Mentions:
JPM
ALXN
XBI
MRNA
...
Pandemic, Democratic Wins Leave Drug Industry at Crossroads
5 years ago - By: Capital Market Laboratories
A Trigger to Get Long: Three Inside Up, RSI, Moving Average Trigger in Immunomedics Inc
5 years ago - By: InvestorPlace
- Mentions:
GILD
7 Stocks That Look Like Great Buyout Targets
5 years ago - By: The Motley Fool
- Mentions:
GILD
What's Driving Gilead Sciences' Growth-Through-Acquisition Strategy
5 years ago - By: The Motley Fool
- Mentions:
GILD
Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?
5 years ago - By: Capital Market Laboratories
Pre-earnings Bullish Momentum Pattern and Trigger in Immunomedics Inc
5 years ago - By: Zacks Investment Research
- Mentions:
GILD
VRTX
HZNP
Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings?
5 years ago - By: Benzinga
- Mentions:
FOLD
JAGX
GILD
DBVT
...
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO
5 years ago - By: Investor's Business Daily
- Mentions:
GILD
Gilead Sciences Gets FDA Approval For Covid-19 Treatment Remdesivir
5 years ago - By: Benzinga
- Mentions:
BXRX
ADCT
NVIV
FMTX
...
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
5 years ago - By: Zacks Investment Research
- Mentions:
MRK
AVEO
SGEN
Seagen Posts Upbeat Top-Line Data From EV-201 Study on Padcev
5 years ago - By: Zacks Investment Research
- Mentions:
AVEO
EBS
CSTL
Immunomedics' Trodelvy Gets Orphan Drug Tag for Glioblastoma
5 years ago - By: Zacks Investment Research
- Mentions:
AVEO
FOLD
AXGT
Axovant's Gene Therapy Gets Rare Pediatric Disease Status
5 years ago - By: Barron's
- Mentions:
GILD
WFC
LLY
BAC
...
Alaska Bought Up Gilead, Lilly, and Wells Fargo Stock. Here’s What It Sold.
5 years ago - By: Zacks Investment Research
- Mentions:
JNJ
SNY
GILD
BMY
...
Pharma M&As Pick Up as Bristol-Myers Offers to Buy MyoKardia
5 years ago - By: Investor's Business Daily
- Mentions:
GILD
REGN
Regeneron Pharmaceuticals, Gilead Sciences Shares Rise As Their Therapies Used To Treat President
5 years ago - By: Barron's
- Mentions:
LUNG
PMVP
PRLD
GRAY
...
Biotech Pulmonx Set to Start Trading
5 years ago - By: Halper Sadeh LLP
- Mentions:
GILD
CBMG
RST
VAR
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, RST, IMMU, VAR
5 years ago - By: WeissLaw LLP
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
Please enable JavaScript to continue using this application.